Q1 2025 Holdings
Filed 2025-05-15 | 14 holdings | $279.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $71.1M | 6,443,940 | 25.5% |
| Merus N V | COM | N5749R100 | $66.0M | 1,568,841 | 23.6% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $35.4M | 733,014 | 12.7% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $35.2M | 5,291,929 | 12.6% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $24.3M | 3,215,722 | 8.7% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $16.1M | 11,057,009 | 5.8% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $11.4M | 7,098,133 | 4.1% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $7.4M | 5,357,347 | 2.6% |
| Precision Biosciences Inc(DTIL) | COM NEW | 74019P207 | $3.7M | 766,051 | 1.3% |
| Ibio Inc(IBIO) | CON NEW | 451033708 | $3.5M | 862,279 | 1.2% |
| Passage BIO Inc | COM | 702712100 | $3.3M | 9,256,953 | 1.2% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $1.3M | 219,247 | 0.5% |
| Neuphoria Therapeutics Inc(NEUP) | COM | 64136E102 | $263.8K | 45,806 | 0.1% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $254.6K | 65,954 | 0.1% |